Devesco Pharmaceuticals Private Limited
About Devesco Pharmaceuticals Private Limited
Data last updated:
Devesco Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 December 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PTC186223. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kamal Harmilapi and Sushil Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Sl – 10 Block L G/F Shopping Complex Hari Nagar, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2019, the company reported a revenue of ₹7.92 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net loss of ₹17,520 (net margin -2.2%) and EBITDA of -₹9,407 (EBITDA margin -1.2%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Devesco Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSl – 10 Block L G/F Shopping Complex Hari Nagar, New Delhi, Delhi, India – 110064
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Devesco Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Devesco Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Devesco Pharmaceuticals Private Limited, buy the company report.
Financials of Devesco Pharmaceuticals Private Limited
FY 2019 filings availableDevesco Pharmaceuticals Private Limited reported revenue of ₹7.92 Lakh (up 49% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 49% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 17%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹7.92 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹9,407 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹17,520 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.2% | ||||
| Net Profit Margin | -2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Devesco Pharmaceuticals Private Limited, buy the company report.
Board of directors of Devesco Pharmaceuticals Private Limited
Devesco Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Harmilapi | Director | 13 Dec 2011 | 14 Years 10 Months | Current |
| Sushil Bhatia | Additional Director | 11 Nov 2019 | 6 Years 11 Months | Current |
Peer comparison
Devesco Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wulo Nutricare Private Limited | ₹7.93 Lakh (FY 2019) | 50.0% | Gurgaon, Haryana, India | |||
| VSK Pharma Private Limited | ₹7.92 Lakh (FY 2024) | 152.0% | New Delhi, Delhi, India | |||
| Devesco Pharmaceuticals Private Limitedthis company | ₹7.92 Lakh (FY 2019) | -₹17,520 | -2.2% | 49.0% | New Delhi, Delhi, India | |
| Avant Pharmaceuticals Private Limited | ₹7.91 Lakh (FY 2025) | -90.0% | New Delhi, Delhi, India | |||
| N. S. Pharmaceuticals Private Limited | ₹7.9 Lakh (FY 2025) | 7.0% | Jarmundi, Jharkhand, India |
To see the full peer comparison of Devesco Pharmaceuticals Private Limited, buy the company report.
Auditor
Devesco Pharmaceuticals Private Limited is audited by KUMAR ARORA & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAR ARORA & ASSOCIATES | FY 2019 | 009936N |
Shareholding
The shareholding of Devesco Pharmaceuticals Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Devesco Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Devesco Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Devesco Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Devesco Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Devesco Pharmaceuticals Private Limited, buy the company report.
Recent activity
Devesco Pharmaceuticals Private Limited has 4 board changes on record since 2011: 2 appointments and 2 cessations. The latest: Nidhi Sagar ceased to be Director on 16 Nov 2019.
Frequently asked questions
Devesco Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 December 2008 (18+ years old) and is registered under CIN U24232DL2008PTC186223.
Devesco Pharmaceuticals has 2 current directors:
- Kamal Harmilapi - Director
- Sushil Bhatia - Additional Director
The latest financial statements of Devesco Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Devesco Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Devesco Pharmaceuticals is U24232DL2008PTC186223. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devesco Pharmaceuticals was incorporated on 30 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Devesco Pharmaceuticals by revenue are Wulo Nutricare Private Limited, VSK Pharma Private Limited, Avant Pharmaceuticals Private Limited, N. S. Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Nidhi Sagar ceased to be Director on 16 Nov 2019. Swaran Kanta ceased to be Director on 16 Nov 2019. Sushil Bhatia was appointed as Additional Director on 11 Nov 2019. Devesco Pharmaceuticals has 4 board changes on record in total.
The registered office of Devesco Pharmaceuticals is at Sl – 10 Block L GF Shopping Complex Hari Nagar, New Delhi, Delhi, India – 110064.
Devesco Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Devesco Pharmaceuticals is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
